Zeno Pharmaceuticals
San Diego, US · Founded 2014 · Delaware corporation
Founders & leadership
AY
Anthony Y. SunExecutive
CG
Cam GallagherExecutive
Reported raises · per SEC filings
Form D private placements$18.3M disclosed across 1 round · 2015
▶$18.3MraisedMar 2016 · 11 investors · PharmaceuticalsRule 506(b)
▶$18.3MraisedMar 2016 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Anthony Y. SunExecutive Officer, Director
- Cam GallagherExecutive Officer, Director
- Offering amount
- $18.3M
- Amount sold
- $18.3M
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Zeno Pharmaceuticals raised?
- Zeno Pharmaceuticals has disclosed $18.3M raised across 1 round.
- Where is Zeno Pharmaceuticals headquartered?
- Zeno Pharmaceuticals is headquartered in San Diego, US.